Bristol-Myers Squibb Co
NYSE:BMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bristol-Myers Squibb Co
NYSE:BMY
|
US |
|
Pierce Group AB (publ)
STO:PIERCE
|
SE |
|
H
|
Hamat Group Ltd
TASE:HAMAT
|
IL |
|
S
|
Sixt SE
XMUN:SIX2
|
DE |
|
M
|
Mitsubishi Chemical Holdings Corp
XBER:M3C
|
JP |
|
Atlas Arteria Group
ASX:ALX
|
AU |
|
Better Plant Sciences Inc
F:YG3
|
CA |
|
Meghmani Organics Ltd
NSE:MOL
|
IN |
|
P
|
PetroChina Co Ltd
DUS:PC6
|
CN |
|
Y
|
Yolo Group SpA
F:X2Y
|
IT |
|
FedEx Corp
NYSE:FDX
|
US |
|
A
|
Americas Gold and Silver Corporation
AMEX:USAS
|
CA |
|
Full Truck Alliance Co Ltd
F:892
|
CN |
|
UniFirst Corp
NYSE:UNF
|
US |
|
S
|
SM Energy Co
SWB:SJL
|
US |
|
I
|
Indegene Ltd
BSE:544172
|
IN |
|
KKR & Co Inc
LSE:0Z1W
|
US |
|
L
|
L'Oreal SA
BMV:ORN
|
FR |
|
S
|
Sanmina Corp
XMUN:SAYN
|
US |
|
W
|
Webjet Ltd
F:WBJ
|
AU |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
S
|
StealthGas Inc
F:S6W
|
GR |
|
China National Chemical Engineering Co Ltd
SSE:601117
|
CN |
|
Arafura Resources Ltd
ASX:ARU
|
AU |
Wall St Price Targets
BMY Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BMY is 63.178 USD with a low forecast of 33.431 USD and a high forecast of 78.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMY's stock price target?
Price Target
63.178
USD
According to Wall Street analysts, the average 1-year price target for BMY is 63.178 USD with a low forecast of 33.431 USD and a high forecast of 78.75 USD.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is -2%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.
